Challenges Spokesperson's Account of an "Agreement to Destroy" the Materials

Lee Sohee of the People Power Party criticized the Ministry of Food and Drug Safety (MFDS), accusing its employees of visiting her office without prior notice and demanding that materials cited in a parliamentary audit be deleted, calling it “obstruction of the parliamentary audit.” Her office had kept clinical trial result documents for verification after the MFDS had left them available for download without authentication, but the agency first demanded that the materials be deleted. Lee said the MFDS had prioritized retrieving materials from the National Assembly over identifying who was responsible for the leak and notifying affected companies.


Lee, a member of the National Assembly’s Health and Welfare Committee, wrote on Facebook on October 16 that MFDS employees had visited her office the previous day and demanded the immediate deletion of clinical trial results she had raised during the parliamentary audit. “They barged in as if they were conducting a search and seizure,” she said.


Lee Sohee of the People Power Party, a member of the National Assembly Health and Welfare Committee. Yonhap News Agency

Lee Sohee of the People Power Party, a member of the National Assembly Health and Welfare Committee. Yonhap News Agency

View original image

During the MFDS audit on October 13, Lee said that 2,672 clinical trial result documents on the Drug Safety Korea website could be downloaded without logging in. Of these, 839 documents contained non-public corporate information, and 2,208 included the mobile phone numbers of people in charge. According to Lee, the documents also included information on COVID-19 treatments funded with hundreds of billions of won in public money, as well as clinical trial data on botulinum toxin, a nationally designated core technology. When the National Assembly requested clinical review documents for Genencell’s COVID-19 treatment, the MFDS refused to submit them, citing trade secrets.


Lee and the MFDS gave conflicting accounts of whether they had discussed destroying the materials. During the audit, when MFDS Minister Oh Yu-kyung requested that the materials be destroyed, Lee’s office replied, “No decision has been made, so please just explain the procedure.” However, an MFDS spokesperson told a reporter that the agency had agreed with Lee’s office to help with the destruction process. Lee said that the staff member who visited her office also confirmed they had never discussed the matter, and that the MFDS told her on October 16 that “there had been no specific agreement.” “They claimed there was an agreement when there wasn’t,” she said, criticizing the agency for “distorting the facts, not clarifying them.”


Lee also took issue with the MFDS’s explanation of how the information was leaked. In an apology issued on October 14, an agency under the MFDS said it had become aware that clinical trial information was leaked through “abnormal access” around midnight on October 12. Lee said this was when her office was looking into the issue. “If ‘abnormal access’ refers to our office preparing for the parliamentary audit, then disclose the evidence for that claim first,” she demanded. Her office is securely retaining the documents to determine how widely they were exposed, with the review to continue through the comprehensive audit on October 27.



“Does deleting materials held by the National Assembly come before notifying affected companies and conducting a comprehensive investigation?” Lee asked. She called on the MFDS to correct the spokesperson’s statement, immediately notify affected companies, and conduct a comprehensive investigation into the scope of the leak. She also urged the agency to distinguish between public and non-public information from the clinical trial registration stage and establish a system to automatically redact personal information.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing